RIZATRIPTAN SANDOZ 10 mg, orodispersible tablet 6 tablets
Active ingredients: Rizatriptan benzoate, Rizatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIZATRIPTAN SANDOZ 10 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 6 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61312299CIP72742295CIP133400927422959Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIZATRIPTANcomprimé | 10 mg · un comprimé | FT |
| BENZOATE DE RIZATRIPTANcomprimé | 14,53 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.